Evidence map›Paper›PMID 37424557›Full record

ArticleAccess microbiology2023

A multiphasic approach to solve misidentification of

Dilini Kumaran, Carmelie Laflamme, Sandra Ramirez-Arcos

Open access · goldAbstract read
In one paragraph

Article in Access microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Draft genome sequence of multidrug-resistantMicrobiology resource announcements · 2025
    Article
  6. Draft genome sequencing of a multidrug-resistantMicrobiology resource announcements · 2025
    Article
  7. Draft genome sequencing of a multidrug-resistantMicrobiology resource announcements · 2025
    Article
  8. Draft genomes of multidrug-resistantMicrobiology resource announcements · 2025
    Article
  9. Article
  10. Draft genome sequencing of a multidrug-resistant and virulentMicrobiology resource announcements · 2025
    Article
  11. Draft genome sequencing of multidrug-resistantMicrobiology resource announcements · 2025
    Article
  12. Draft genome sequencing of a multidrug-resistantMicrobiology resource announcements · 2025
    Article
  13. Draft genome sequencing ofMicrobiology resource announcements · 2025
    Article
  14. Whole-genome sequencing ofMicrobiology resource announcements · 2024
    Article
  15. Draft genome sequencing ofMicrobiology resource announcements · 2024
    Article
  16. Draft genome sequencing ofMicrobiology resource announcements · 2024
    Article
  17. Draft genome sequencing ofMicrobiology resource announcements · 2024
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dilini KumaranCanadian Blood Services, Ottawa, Ontario, Canada.
Carmelie LaflammeCanadian Blood Services, Ottawa, Ontario, Canada.
Sandra Ramirez-ArcosCanadian Blood Services, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0003-0705-4987
University of Ottawa · CACanadian Blood Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin flora bacteria, such as

Indexed as

16S RNAAtopobium vaginaeCutibacterium acnesMALDI-TOFmisidentificationmultiphasic identificationVITEK 2

Identifiers

PMID37424557
PMCPMC10323807
OpenAlexW4380992985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.